Strategies inspired by opt-in, opt-out approach of pensions
The health plan cost increases besieging Canadian companies are driven by many factors, including the availability of specialty drugs for treating rare and complex diseases. But the primary driver of drug cost inflation is a lack of informed patient decisions — decisions employers have the power to influence.
